BioSpace News Archive

United Therapeutics Corporation announced its financial results for the first quarter ended March 31, 2018.

Aroa Biosurgery and United States medical products company Hydrofera are launching Appulse in North America.

Dr. Alan J. Bauman, MD brings SmartGraft®, a minimally invasive and permanent hair restoration treatment for both men and women, to his state of the art practice in Boca Raton, Florida.

Future Meat Technologies has announced a $2.2 million seed investment round co-led by Tyson Ventures.

Bio-Techne Corporation announced that its Board of Directors has decided to pay a dividend of $0.32 per share for the quarter ended March 31, 2018.

Bio-Techne Corporation reported its financial results for the third quarter ended March 31, 2018.

Centene Corporation announced that its Florida subsidiary, Sunshine Health, has been notified by the Florida Agency for Health Care Administration (AHCA) of its intent to award a contract to provide physical and behavioral health care services through Florida’s Statewide Medicaid Managed Care (SMMC) Program.

Halyard Health, Inc. reported first quarter 2018 results and provided its 2018 earnings outlook.

Janssen Biotech, Inc. announced that it has entered into a definitive agreement under which it will acquire BeneVir Biopharm, Inc. (BeneVir), a privately-held, biopharmaceutical company specializing in the development of oncolytic immunotherapies.

Realm Therapeutics plc announces it has confidentially submitted a registration statement to the United States Securities and Exchange Commission (SEC) in connection with a proposed listing of American Depositary Shares (ADSs) representing the Company’s ordinary shares on the Nasdaq Global Market (Nasdaq).